Humanigen Inc (HGENQ)

[cowtown jay]

I was actually glad to see the article appear today regarding HC Wainwright's share price projection of $28. It hasn't always been true that I was glad to see that news.

https://www.tipranks.com/news/article/humanigen-a-transformative-year-awaits-says-analyst?utm_source=advfn.com&utm_medium=referral

For one thing, I've always thought our potential was higher than what Pantginis was estimating. I pointed out that another Wainwright analyst was projecting a share price for VIR (Sotrovimab) of $135, and was looking to increase it even further.

https://finance.yahoo.com/news/glaxosmithkline-vir-biotechnology-sotrovimab-antibody-141200627.html

VIR's share price hit a 52 week low today. Aside from the Healthcare Sector impact on price, VIR's drug use was de-authorized by the FDA last month. VIR had a good 1st Qtr because, "To date, and consistent with prior disclosures, binding agreements have been received for the sale of approximately 1.7 million doses of sotrovimab worldwide (with approximately 700,000 of those doses delivered in 2021)."

https://ih.advfn.com/stock-market/NASDAQ/vir-biotechnology-VIR/stock-news/88026143/vir-biotechnology-provides-corporate-update-and-re

So the US government does not have a stockpile of an effective therapeutic to replace the almost 2M treatments they were trying to obtain.

If Vanden Bossche is correct about infectiousness being the key metric to use to measure the pandemic status, we could see a very large spike in Covid severity that could far surpass what analysts and healthcare professionals are anticipating.